Stock Chat

Join Stock Chat and Discuss this DD Report

We are excited to present Itamar Medical, Ltd. (OTC: ITMMF).

Full DD Report for ITMMF

Recent News from (OTC: ITMMF)

Itamar Medical reports Q4 results
Itamar Medical ( OTCPK:ITMMF ): Q4 operating loss of $0.5M More news on: Itamar Medical, Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: March, 22 2018 10:41
Clarification and Apology to the American Academy of Sleep Medicine Regarding March 16 Press Release by Itamar Medical
CAESAREA, Israel , March 19, 2017 /PRNewswire/ -- Itamar Medical Ltd. (TASE: ITMR) wishes to clarify its recent press release, "An Important Recognition in the US Market for the WatchPAT™ Device" from March 16th . Certain language in the press release mistakenly implies that t...
Source: PR Newswire
Date: March, 19 2017 09:02
An Important Recognition in the US Market for the WatchPAT(TM) Device: The American Academy of Sleep Medicine ("AASM") has Formally Endorsed Itamar Medical's WatchPAT(TM) Technology to Diagnose Sleep Apnea, Based on Published Evidence
CAESAREA, Israel , March 16, 2017 /PRNewswire/ -- Itamar Medical Ltd. (TASE: ITMR) reports that AASM, the leading medical association of sleep medicine physicians in the United States , has published an updated version of its Clinical Practice Guideline for Diagnosis of Sleep Apnea ...
Source: PR Newswire
Date: March, 16 2017 10:00
FDA Clears Expanded Indication for Itamar Medical's WatchPAT(TM) Sleep Apnea Diagnostic Device for Adolescents
CAESAREA, Israel , July 28, 2016 /PRNewswire/ -- Itamar Medical (TASE:ITMR), which develops and markets non-invasive diagnostic medical devices for sleep-related breathing disorders, received FDA clearance to expand the medical indication of WatchPAT for sleep apnea diagnosis. Under thi...
Source: PR Newswire
Date: July, 28 2016 08:00


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report.

About Itamar Medical, Ltd. (OTC: ITMMF)

Logo for Itamar Medical, Ltd. (OTC: ITMMF)

Itamar Medical Ltd is a medical technology company focused on the development, marketing and sales of diagnostic products based on its proprietary PAT platform technology, developed by a team of leading clinicians in sleep medicine and cardiology together with biomedical engineers and physicists.


Contact Information



Current Management

  • Gilad Glick / CEO, President
  • Shaul Sharoni / CFO
  • Koby Sheffy / EVP, CTO
  • Shlomo Ayanot / VP, Eng., VP, Ops.
  • Dafna Katz / VP, Mkt.
  • Efrat Litman / VP, R amp D
  • Eldad Singer / VP, Sales
  • Shahar Cohen / Controller
  • Shaul Sharoni /

Current Share Structure

  • Market Cap: $39,959,910 - 03/09/2018
  • Issue and Outstanding: 133,199,700 - 12/15/2011


Daily Technical Chart for (OTC: ITMMF)

Daily Technical Chart for (OTC: ITMMF)

Stay tuned for daily updates and more on (OTC: ITMMF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ITMMF)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

The Subway Trader



Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ITMMF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $0 from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of ITMMF and does not buy, sell, or trade any shares of ITMMF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by The Subway Trader. All rights reserved. Our Full Disclaimer:



Release this Report to Investors

Via Email

Via Text


If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us